HDAC-IN-31

Overview

HDAC-IN-31 is a potent, selective and orally active HDAC inhibitor with IC 50 s of 84.90, 168.0, 442.7, >10000 nM for HDAC1 , HDAC2 , HDAC3 , HDAC8 , respectively. HDAC-IN-31 induces apoptosis and cell cycle arrests at G2/M phase. HDAC-IN-31 shows good antitumor efficacy. HDAC-IN-31 has the potential for the research of diffuse large B-cell lymphoma.

Application

Products | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > Epigenetics | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Apoptosis | Products > Signaling Pathways > HDAC

Product Information

• Catalog No.: HY-144293
• CAS No.: 1916505-13-9
• Molecular Formula: C25H24N4O2
• Molecular Weight: 412.48
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source